rs141589525

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_015046.7(SETX):​c.7870G>T​(p.Asp2624Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,614,110 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00070 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000087 ( 0 hom. )

Consequence

SETX
NM_015046.7 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 0.981
Variant links:
Genes affected
SETX (HGNC:445): (senataxin) This gene encodes a protein named for its homology to the Sen1p protein of fungi which has RNA helicase activity encoded by a domain at the C-terminal end of the protein. The protein encoded by this gene contains a DNA/RNA helicase domain at its C-terminal end which suggests that it may be involved in both DNA and RNA processing. Mutations in this gene have been associated with ataxia-ocular apraxia-2 (AOA2) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069812536).
BP6
Variant 9-132264403-C-A is Benign according to our data. Variant chr9-132264403-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 468527.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=3}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000696 (106/152244) while in subpopulation AFR AF= 0.00221 (92/41544). AF 95% confidence interval is 0.00185. There are 1 homozygotes in gnomad4. There are 46 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SETXNM_015046.7 linkuse as main transcriptc.7870G>T p.Asp2624Tyr missense_variant 26/26 ENST00000224140.6 NP_055861.3 Q7Z333-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SETXENST00000224140.6 linkuse as main transcriptc.7870G>T p.Asp2624Tyr missense_variant 26/261 NM_015046.7 ENSP00000224140.5 Q7Z333-1
SETXENST00000436441.5 linkuse as main transcriptc.2683G>T p.Asp895Tyr missense_variant 17/175 ENSP00000409143.1 X6RI79
SETXENST00000477049.1 linkuse as main transcriptn.1020G>T non_coding_transcript_exon_variant 5/53

Frequencies

GnomAD3 genomes
AF:
0.000684
AC:
104
AN:
152126
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000163
AC:
41
AN:
251484
Hom.:
0
AF XY:
0.0000956
AC XY:
13
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00209
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000869
AC:
127
AN:
1461866
Hom.:
0
Cov.:
30
AF XY:
0.0000784
AC XY:
57
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.00263
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000153
Gnomad4 OTH exome
AF:
0.000215
GnomAD4 genome
AF:
0.000696
AC:
106
AN:
152244
Hom.:
1
Cov.:
32
AF XY:
0.000618
AC XY:
46
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.00221
Gnomad4 AMR
AF:
0.000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000792
Hom.:
0
Bravo
AF:
0.000627
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000239
AC:
29
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2024SETX: BS2 -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 23, 2022In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJun 05, 2023- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 23, 2019The p.D2624Y variant (also known as c.7870G>T), located in coding exon 24 of the SETX gene, results from a G to T substitution at nucleotide position 7870. The aspartic acid at codon 2624 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, this variant is unlikely to be causative of juvenile amyotrophic lateral sclerosis 4; however, its contribution to the development of spinocerebellar ataxia with axonal neuropathy 2 is uncertain. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingAthena DiagnosticsJan 25, 2021- -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;C1865409:Amyotrophic lateral sclerosis type 4 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 24, 2023- -
SETX-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 25, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.16
.;T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.55
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.52
T;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.0070
T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Benign
1.4
.;L
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-2.1
N;N
REVEL
Benign
0.28
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.012
D;D
Polyphen
0.94
.;P
Vest4
0.27
MVP
0.75
MPC
0.31
ClinPred
0.058
T
GERP RS
3.1
Varity_R
0.073
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141589525; hg19: chr9-135139790; API